MetLife, Inc.(MET)Earnings, Financials & Key RatiosMetLife, Inc. (MET) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the forward P/E of 8.67 suggests potential undervaluation, the persistent volatility in legacy blocks and the 82.6% loss ratio spike observed in 2025Q3 warrant a cautious approach until earnings stability improves.
MetLife, Inc. (MET) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
MetLife, Inc. (MET) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $2.42vs $2.27+6.6% | $19.1Bvs $19.5B-2.1% |
| Q1 2026 | Feb 4, 2026 | $2.58vs $2.34+10.3% | $23.8Bvs $27.2B-12.5% |
| Q4 2025 | Nov 5, 2025 | $2.34vs $2.31+1.3% | $16.9Bvs $18.6B-9.4% |
| Q3 2025 | Aug 6, 2025 | $2.02vs $2.15-6.0% | $17.3Bvs $18.5B-6.4% |
Recent stock market news and headlines for MetLife, Inc. (MET)
For many pet parents, saying goodbye to a beloved dog or cat is one of life's most difficult experiences. MetLife Pet Insurance is introducing a new Memorial T
NEW YORK--(BUSINESS WIRE)-- #animalwelfare--For many pet parents, saying goodbye to a beloved dog or cat is one of life's most difficult experiences. MetLife Pet Insurance is introducing a new Memorial Tree Program to help honor that bond, alongside grief counseling services that support pet parents through end-of-life decisions and the months that follow. MetLife Pet Insurance research underscores the depth of that bond: 95% of Americans consider their pet to be family, and 50% say they have grieved a pet's de.
Key metrics vs top competitors for MetLife, Inc. (MET)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $91.67 | $59.77B | 19.10 | 10.22% | 4.38% | 11.93% | 2.48% | |
| $115.47 | $40.16B | 11.30 | -14.01% | 5.62% | 10.26% | — | |
| $39.19 | $7.49B | 6.71 | 1.24% | 9.14% | 16.79% | — | |
| $89.20 | $14.41B | 20.84 | 2.07% | 5.87% | 7.07% | — | |
| $112.88 | $24.38B | 21.50 | -3.11% | 10.03% | 12.72% | — | |
| $46.98 | $13.23B | -9.73 | -6.21% | -7.26% | -36.74% | — |
MetLife, Inc. (MET) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MetLife, Inc. (MET) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 6, 2026·SEC
Apr 7, 2026·SEC
Mar 5, 2026·SEC
Get notified when MET posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MetLife, Inc. (MET) stock FAQ — growth, dividends, profitability & financials explained
MetLife, Inc. (MET) grew revenue by 10.2% over the past year. This is steady growth.
Yes, MetLife, Inc. (MET) is profitable, generating $3.62B in net income for fiscal year 2025 (4.4% net margin).
Yes, MetLife, Inc. (MET) pays a dividend with a yield of 2.48%. This makes it attractive for income-focused investors.
MetLife, Inc. (MET) has a return on equity (ROE) of 11.9%. This is reasonable for most industries.
MetLife, Inc. (MET) has a combined ratio of 94.0%. A ratio below 100% indicates underwriting profitability.
